Why Catalyst?
Many biotech start-ups and SMEs develop groundbreaking innovations but face challenges when it comes to convincing investors or transitioning their research into clinical development.
I support every phase of the development pipeline – from conceptualization and clinical studies to data analysis. My goal: To act as a catalyst in advancing diagnostics and therapies with a clear, strategic approach.
With experience in investor presentations, scientific lectures, and executive-level communication, I help transform complex innovations into compelling narratives – for investors, experts, and stakeholders.
Preclinical Studies
Preclinical development requires scientific precision and strategic foresight. I establish a solid foundation for the clinical phase and regulatory approval—with clear strategies that combine scientific excellence and regulatory requirements.
Communication
Successful ideas require strong communication. I develop pitch decks, refine pitches, and support investor meetings to present innovations convincingly. Additionally, I assist with conference presentations and engaging key opinion leaders (KOLs) to enhance visibility within professional circles and among stakeholders.
Clinical Studies
Clinical trials are the most cost-intensive step in development. I support the entire process—from planning to regulatory submission—optimizing efficiency, quality, and success rates.
Development Strategy
Not every idea should be pursued. I help focus on the most promising assets, allocate resources strategically, and design an efficient development strategy.
Financing
Sustainable funding requires targeted strategies. I develop and support financing strategies—from leveraging public grants to strategic investor outreach and networking—to establish a stable financial foundation.
Data Analysis
Complex preclinical and clinical data come with challenges and uncertainties. Through in-depth analysis and modern methods, I help identify patterns, assess risks, and optimize decision-making processes.